---
layout: paper
title: Publications in 2016
image: /images/barbados/barbados.gif
authors:  Hallett M  
year: 2016
---


<br> <br>

<em>Lesurf R</em>, Ragle Aure Miriam,Haberg Mork H, Vitelli V, Kleivi K, Lundgren S, Borresen-Dale A-L, Kristensen VN, Warnberg F, <strong>Hallett M</strong>, Sorlie T (2016) Molecular features of subtype-specific progression from ductal carcinoma in situ to invasive breast cancer. Cell Reports.16(4): 1166-79. 

Boucher B, <em>Lee AY</em>, <strong>Hallett M</strong>, Jenna S (2016) Structural and functional characterization of a Caenorhabditis elegans genetic interaction network within pathways. PLoS computational biology. 12(2), doi: 10.1371/journal.pcbi.1004738. 

Cyr-Depauw C, Northey JJ, Tabariès S, Annis MG, Dong Z, <em>Cory S</em>, <strong>Hallett M</strong>, Rennhack JP, Andrechek ER, Siegel PM (2016) Chordin-Like 1 suppresses Bone Morphogenetic Protein 4 Induced breast cancer cell migration and invasion. Molecular and cellular biology. 36(10):1509-25.

Boulay PL, Mitchell L, Turpin J, Huot-Marchand JÉ, Lavoie C, Sanguin-Gendreau V, Jones L, Mitra S, <em>Livingstone JM</em>, Campbell S, <strong>Hallett M</strong>, Mills GB, Park M, Chodosh L, Strathdee D, Norman JC, Muller WJ (2016) Rab11-FIP1C is a critical negative regulator in ErbB2-mediated mammary tumor progression.  Cancer research. 76(9):2662-74.

Turpin J, Ling C, Crosby EJ, Hartman ZC, Simond AM, Chodosh LA, Rennhack JP, Andrechek ER, <em>Ozcelik J</em>, <strong>Hallett M</strong>, Mills GB, Cardiff RD, Gray JW, Griffith OL, Muller WJ (2016) The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment. Oncogene. 35(47): 6053-64.

Jones LM, Broz ML, Ranger JJ, <em>Ozcelik J</em>, Ahn R, Zuo D, Ursini-Siegel J, <strong>Hallett M</strong>, Krummel M, Muller MJ (2016) Stat3 establishes an immunosuppressive microenvironment during the early stages of breast carcinogenesis to promote tumor growth and metastasis. Cancer Research 76(6):1416-28.